408 related articles for article (PubMed ID: 32013913)
41. Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy.
Sato T; Tsuboi K; Nakashima H; Emi K
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):665-671. PubMed ID: 27770210
[TBL] [Abstract][Full Text] [Related]
42. Intravitreal conbercept improves outcome in patients undergoing vitrectomy for proliferative diabetic retinopathy: A systematic review and meta-analysis.
Pranata R; Vania A
J Evid Based Med; 2020 May; 13(2):116-124. PubMed ID: 32167242
[TBL] [Abstract][Full Text] [Related]
43. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.
Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K
Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852
[TBL] [Abstract][Full Text] [Related]
44. Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial.
Li S; Guo L; Zhou P; Tang J; Wang Z; Zhang L; Zhao M; Qu J
Eye Vis (Lond); 2022 Dec; 9(1):44. PubMed ID: 36451252
[TBL] [Abstract][Full Text] [Related]
45. Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial.
Guo H; Li W; Nie Z; Zhang X; Jiao M; Bai S; Duan N; Li X; Hu B
Trials; 2023 Oct; 24(1):685. PubMed ID: 37875997
[TBL] [Abstract][Full Text] [Related]
46. Effect of Adjunctive Intravitreal Conbercept Injection at the End of 25G Vitrectomy on Severe Proliferative Diabetic Retinopathy: 6-Month Outcomes of a Randomised Controlled Trial.
Li H; Niu Y; Rong A; Bi Y; Xu W; Cui H
Ophthalmol Ther; 2023 Apr; 12(2):1173-1180. PubMed ID: 36752956
[TBL] [Abstract][Full Text] [Related]
47. Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Glassman AR; Beaulieu WT; Maguire MG; Antoszyk AN; Chow CC; Elman MJ; Jampol LM; Salehi-Had H; Sun JK;
JAMA Ophthalmol; 2021 Jul; 139(7):725-733. PubMed ID: 33956075
[TBL] [Abstract][Full Text] [Related]
48. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
Li S; Yang Y; Zou J; Zeng J; Ding C
BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
Hu L; Chen Q; Du Z; Wang W; Zhao G
Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
[TBL] [Abstract][Full Text] [Related]
50. Gas Tamponade for the Prevention of Postoperative Vitreous Hemorrhaging After Diabetic Vitrectomy: A Randomized Clinical Trial.
Rush RB; Velazquez JC; Rosales CR; Rush SW
Am J Ophthalmol; 2022 Oct; 242():173-180. PubMed ID: 35764103
[TBL] [Abstract][Full Text] [Related]
51. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
[TBL] [Abstract][Full Text] [Related]
52. COMPARISON OF THE EFFICACY AND SAFETY OF RANIBIZUMAB 0.5 MG VERSUS 1.0 MG WITH PARS PLANA VITRECTOMY FOR THE TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY: A Randomized Controlled Trial.
Su T; Lai D; Wu Y; Gu C; He S; Meng C; Cai C; Zhang J; Luo D; Chen J; Zheng Z; Qiu Q
Retina; 2024 Apr; 44(4):680-688. PubMed ID: 38011844
[TBL] [Abstract][Full Text] [Related]
53. Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial.
Arevalo JF; Lasave AF; Kozak I; Al Rashaed S; Al Kahtani E; Maia M; Farah ME; Cutolo C; Brito M; Osorio C; Navarro P; Wu L; Berrocal MH; Morales-Canton V; Serrano MA; Graue-Wiechers F; Sabrosa NA; Alezzandrini AA; Gallego-Pinazo R;
Am J Ophthalmol; 2019 Nov; 207():279-287. PubMed ID: 31095954
[TBL] [Abstract][Full Text] [Related]
54. Intraocular pharmacokinetics of anti-vascular endothelial growth factor agents by intraoperative subretinal versus intravitreal injection in silicone oil-filled eyes of proliferative diabetic retinopathy: a randomized controlled pilot study.
Yao TT; Yang Y; Jin XL; Wang YX; Zhou YL; Xu AJ; He FL; Wang ZY
Acta Ophthalmol; 2020 Nov; 98(7):e795-e800. PubMed ID: 32114709
[TBL] [Abstract][Full Text] [Related]
55. The fellow eye effect of unilateral intravitreal conbercept injections in eyes with diabetic macular edema.
Di Y; Li Z; Ye J; Li L; Li B; Yu R
Acta Diabetol; 2020 Aug; 57(8):1001-1007. PubMed ID: 32215730
[TBL] [Abstract][Full Text] [Related]
56. Photocoagulation Up to Ora Serrata in Diabetic Vitrectomy to Prevent Recurrent Vitreous Hemorrhage.
Yoon CY; Shin MC; Kim P; Shin YK; Kim WJ
Korean J Ophthalmol; 2023 Dec; 37(6):477-484. PubMed ID: 37899285
[TBL] [Abstract][Full Text] [Related]
57. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.
Kim DY; Kim JG; Kim YJ; Joe SG; Lee JY
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7040-6. PubMed ID: 25298415
[TBL] [Abstract][Full Text] [Related]
58. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Smith JM; Steel DH
Cochrane Database Syst Rev; 2011 May; (5):CD008214. PubMed ID: 21563165
[TBL] [Abstract][Full Text] [Related]
59. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
Xu Y; Rong A; Xu W; Niu Y; Wang Z
BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
[TBL] [Abstract][Full Text] [Related]
60. Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy.
Mao JB; Wu HF; Chen YQ; Zhao SX; Tao JW; Zhang Y; Zheng B; Wang L; Shen LJ
Int J Ophthalmol; 2018; 11(7):1217-1221. PubMed ID: 30046542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]